Press release AFFLUENT MEDICAL
Affluent Medical announces the completion of bridge financing of 3.5 million euros through a capital increase subscribed by its main shareholders.
• Major shareholders participate in bridge financing to continue exploring options for obtaining long-term financing
• The company will continue to execute the key milestones of the roadmap
Affluent Medical today announces the completion of bridge financing of 3.5 million euros with its main shareholders. This financing was carried out in the form of a capital increase with elimination of shareholders’ preferential subscription rights for the benefit of a category of beneficiaries. The participating shareholders are: Truffle Capital, LCEA, Ginko Invest, Denos and Hayk Holding.